Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000113 · ClinicalTrials.gov registry record · Phase 3
Correction of Myopia Evaluation Trial (COMET)
A Phase 3 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 3
- Development phase
- 469
- Enrollment target
NCT00000113 is a Phase 3 study that has completed, run by Stony Brook University. The registered enrollment target is 469 participants.
The verdict
NCT00000113, a Phase 3 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 469 participants
- Enrollment target
Study Summary
To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography. To describe the natural history of juvenile-onset myopia in a group of children receiving conventional treatment (single vision lenses).
Interventions
- OTHER Progressive Addition Lenses
- OTHER single vision lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 1997-09 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000113
The ClinicalTrials.gov registry entry for NCT00000113 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 469 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Progressive Addition Lenses is the first listed.
NCT00000113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000113 about?
NCT00000113 is a clinical study titled "Correction of Myopia Evaluation Trial (COMET)". To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography. To...
What is the current status of trial NCT00000113?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 469 participants. The study started on 1997-09. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00000113?
The interventions under investigation include: Progressive Addition Lenses (OTHER), single vision lenses (OTHER).
Who is sponsoring clinical trial NCT00000113?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.